Patents by Inventor Jeremy Stephen Parker

Jeremy Stephen Parker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210308275
    Abstract: A conjugate comprising a protein or a peptide, a linker and an active agent, wherein the linker comprises the moiety of formula (III): (III) wherein two of A1, A2 and A3 are N and the other of A1, A2 and A3 is CH; X is selected from N, O and S, and Pep indicates where the moiety is linked to the protein or peptide, either directly or indirectly.
    Type: Application
    Filed: July 31, 2018
    Publication date: October 7, 2021
    Inventors: Jeremy Stephen Parker, Hannah Fiona Sore, David Robert Spring, Stephen James Walsh
  • Patent number: 7973178
    Abstract: A process for making a compound of formula (I), which is useful as an intermediate to compounds which activate glucokinase, is described, (wherein P1, R1 and R2 are as defined in the description).
    Type: Grant
    Filed: November 27, 2006
    Date of Patent: July 5, 2011
    Assignee: AstraZeneca AB
    Inventors: Phillip Anthony Hopes, Jeremy Stephen Parker, Bharti Patel, Matthew James Welham
  • Publication number: 20100324328
    Abstract: A process for isolating a compound of formula (I) or a salt thereof, where X and R1 are as defined in the specification, from a mixture containing it, and the corresponding diacid and dihydroxy derivative, said process comprising (i) adding to an organic solution containing said compounds, water and a one or more salts, all of which are bases selected from a carbonate or hydrogen carbonate base, (ii) separating the aqueous phase containing the compound of formula (II) from the organic phase containing the compounds of formula (I) and (III); then (iii) recovering the compound of formula (I) from remaining organic phase. The process provides for efficient isolation of the target compound, even on a large scale.
    Type: Application
    Filed: June 25, 2008
    Publication date: December 23, 2010
    Applicant: ASTRAZENECA AB
    Inventors: Jeremy Stephen Parker, Evan William Snape
  • Patent number: 7700640
    Abstract: A process for making a compound of formula (I), said process comprising a) reacting a compound of formula (II) with: i) a compound of formula (III) by nucleophilic aromatic substitution of X2 and ii) a compound of formula (IV) for example by nucleophilic aromatic substitution b) where necessary, converting X1 to a carboxylic acid; and c) coupling of the carboxylic acid group to an appropriate heterocyclic amine; wherein all variables are as defined in the description.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: April 20, 2010
    Assignee: AstraZeneca AB
    Inventors: Philip Cornwall, David Simon Ennis, Melvyn Edward Giles, Jacob Robert James Perkins, Shelly Louise Jenkin, Jeremy Stephen Parker, Bharti Patel
  • Publication number: 20080300412
    Abstract: A process for making a compound of formula (I), which is useful as an intermediate to compounds which activate glucokinase, is described, (wherein P1, R1 and R2 are as defined in the description).
    Type: Application
    Filed: November 27, 2006
    Publication date: December 4, 2008
    Inventors: Phillip Anthony Hopes, Jeremy Stephen Parker, Bhari Patel, Matthew James Welham
  • Publication number: 20080200694
    Abstract: A process for making a compound of formula (I), said process comprising a) reacting a compound of formula (II) with: i) a compound of formula (III) by nucleophilic aromatic substitution of X2 and ii) a compound of formula (IV) for example by nucleophilic aromatic substitution b) where necessary, converting X1 to a carboxylic acid; and c) coupling of the carboxylic acid group to an appropriate heterocyclic amine; wherein all variables are as defined in the description.
    Type: Application
    Filed: October 11, 2005
    Publication date: August 21, 2008
    Inventors: Philip Cornwall, David Simon Ennis, Melvyn Edward Giles, Jacob Robert James Perkins, Shelly Louise Jenkin, Jeremy Stephen Parker, Bharti Patel
  • Patent number: 7411074
    Abstract: A process for preparing a compound of formula (I) where R4 and R5 are as defined in the specification; and R6 is hydrogen or a protecting group, which process comprises cyclisation of a compound of formula (II) where R4, R5 and R6 are as defined in relation to formula (I), and R7 is nitrogen-protecting group, and removing the group R7—, and thereafter if desired or necessary, removing any protecting group R6 to obtain the corresponding carboxylic acid. Novel intermediates and the use of the products in the preparation of pharmaceutical compounds is also described and claimed.
    Type: Grant
    Filed: September 29, 2003
    Date of Patent: August 12, 2008
    Assignee: AstraZeneca AB
    Inventors: Paul Murray, Jeremy Stephen Parker, Paul Schofield, Andrew Stocker